Loading...
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pa...
Na minha lista:
| Udgivet i: | Antiviral Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Authors. Published by Elsevier B.V.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8274277/ https://ncbi.nlm.nih.gov/pubmed/34265358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2021.105137 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|